Last reviewed · How we verify

NCT03813680

Passive Vertebral Mobilization and Propriocemptive Neuromuscular Techniques in Mechanical Neck Pain

Completed NA Last updated 11 March 2021
What this trial tests

NA trial testing Passive Vertebral Mobilization in Mechanical Neck Pain in 90 participants. Completed in 22 March 2018.

Timeline
20 September 2015
Primary endpoint
30 September 2017
22 March 2018

Quick facts

Lead sponsorIsra University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment90
Start date20 September 2015
Primary completion30 September 2017
Estimated completion22 March 2018

Drugs / interventions tested

Conditions studied

Sponsor

Isra University

Who can join

Adults 18 to 65, any sex, with Mechanical Neck Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to determine the effectiveness of Passive Vertebral Mobilization (PVM) and Proprioceptive Neuromuscular Techniques (PNF) in reducing pain, disability and improving quality of life in patients with Mechanical Neck Pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparative effectiveness of proprioceptive neuromuscular facilitation and passive vertebral mobilization for neck disability in patients with mechanical neck pain: A randomized controlled trial.
    Ashfaq M, Babur MN, Malick WH, Hussain MA, et al · · 2022 · cited 3× · PMID 35710215 · DOI 10.1016/j.jbmt.2022.02.009

Verify or expand the search:

Other recruiting trials for Mechanical Neck Pain

Currently open trials in the same condition.

Other Isra University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03813680.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing